Stockreport

Alterity Therapeutics up big on advancement of ATH434 for Parkinsonian disorder [Seeking Alpha]

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF Alterity Therapeutics (NASDAQ:ATHE71%receivingAlterity reached agreement with the agency on the non-clinical investigations required to support the mid-stage study, alon [Read more]